Saturday, June 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home European Markets

Nel ASA Pays $7.5M to End a Lawsuit, but the Market Sees a Bigger Problem: No Orders

SiterGedge by SiterGedge
June 13, 2026
in European Markets, Hydrogen, Mergers & Acquisitions, Renewable Energy
0
Nel ASA Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Nel ASA settled its legal dispute with Iwatani Corporation of America on June 7, agreeing to pay $7.5 million to close the chapter on a dispute over hydrogen refuelling equipment in California. Investors, however, barely blinked. By the end of the week, the water beaker’s shares had tumbled 8% to €0.24 – extending a slide that has now erased nearly 35% from the stock’s 52-week high of €0.37 reached on May 25.

The market’s cold shoulder stems from a far deeper concern: a near-total collapse in new business. Nel booked just 85 million Norwegian kroner in orders during the first quarter of 2026, a 73% plunge from the same period a year ago. Its order backlog shrank to 1.113 billion kroner, down 24% year-on-year, while revenue slipped to 148 million kroner. The EBITDA loss narrowed slightly to -100 million kroner from -115 million kroner, but the bottom line remains firmly in the red. Management has acknowledged that customers are dragging their feet on large-scale electrolyser projects, forcing the company to cut costs, adjust production, and reduce working capital.

The legal settlement with Iwatani and Cavendish Hydrogen ASA puts an end to a distraction that had been hanging over Nel since February 2024. Yet removing one uncertainty does nothing to fill the order pipeline – a reality that has kept the selling pressure on. Despite the recent rout, the stock is still up 9% over the past twelve months and has gained 24% year-to-date, reflecting the sharp rally that preceded the current downturn. But analysts remain wary: a majority currently recommend selling the shares.

Should investors sell immediately? Or is it worth buying Nel ASA?

The technical picture offers little comfort. At €0.24, Nel sits roughly 9% below its 50-day moving average of €0.26, which now acts as the first resistance level. Below that, the 100-day average at €0.23 and the 200-day average at €0.21 provide potential support zones. The relative strength index stands at 37.7 – bearish but not oversold, leaving room for further declines. With annualised 30-day volatility above 92%, sharp moves in either direction remain a real possibility.

Nel does have a financial cushion – 1.443 billion kroner in cash at the end of the quarter – and a new product catalyst in the form of its latest alkaline pressure electrolyser platform unveiled in May. Whether that translates into concrete orders will determine the stock’s trajectory far more than any technical support line. The next make-or-break moment arrives on July 15, when Nel releases its half-year report. Until then, the market is left watching for any sign of a rebound in order intake. Without it, even a clean legal slate won’t be enough to arrest the slide.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from June 13 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 13.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
SiterGedge

SiterGedge

Related Posts

Partners Group Stock
Analysis

With Shares Down 30%, Partners Group Insiders Buy $20 Million as $1.5 Billion Secondaries Fund Takes Off

June 13, 2026
Deutsche Telekom Stock
DAX

Deutsche Telekom Balances Operational Wins with Merger Overhang as Buybacks Continue

June 13, 2026
BioNTech Stock
Dividends

BioNTech Bets Big on Oncology as $1 Billion Buyback and First FDA Filing Converge

June 12, 2026
Next Post
POET Technologies Stock

POET Technologies: A $400 Million Production Bet Overshadowed by a June 29 Courtroom Clock

Deutz AG Stock

Deutz’s Dual-Pivot Strategy Gains Traction at Eurosatory, but Investors Demand Hard Orders

Palantir Stock

Palantir’s Twin Wins: McCarthy and Kirkland & Ellis Deals Fail to Lift Stock Amid AI Sector Anxiety

Recommended

Analyst Optimistic about Eli Lilly Cos Promising Future

2 years ago

Amneal Pharmaceuticals Reports Strong Financial Results for 2023 Sets Ambitious Goals for 2024

2 years ago
Prudential Stock

Is Prudential Stock Signaling a Major Rebound?

9 months ago
Microsoft Stock

Microsoft’s Strategic Pivot: Leadership Reshuffle and New AI Subscription Target Mass Market

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

POET Technologies: A $400 Million Production Bet Overshadowed by a June 29 Courtroom Clock

Nel ASA Pays $7.5M to End a Lawsuit, but the Market Sees a Bigger Problem: No Orders

Redwood AI’s Grand Plans for Africa and Quantum Computing Remain Unbacked as Shares Tumble

Strategy’s First Bitcoin Sale in Years Fuels Dividend Acceleration as Stock Trades at Deep Discount

Ethereum’s Accumulation Paradox: Staking Queue Hits 50 Days as Fidelity Engineers a $28.6 Million Coup

Green Bridge Metals: Historic Policy Support Can’t Halt the Slide as Minnesota Drilling Awaits Answers

Trending

Micron Stock
AI & Quantum Computing

Micron’s Index Upgrade Sets Off a $1.1 Trillion Index Rebalancing Act

by Kennethcix
June 13, 2026
0

The calendar is suddenly crowded with catalysts for Micron Technology. On June 26, FTSE Russell will induct...

Palantir Stock

Palantir’s Twin Wins: McCarthy and Kirkland & Ellis Deals Fail to Lift Stock Amid AI Sector Anxiety

June 13, 2026
Deutz AG Stock

Deutz’s Dual-Pivot Strategy Gains Traction at Eurosatory, but Investors Demand Hard Orders

June 13, 2026
POET Technologies Stock

POET Technologies: A $400 Million Production Bet Overshadowed by a June 29 Courtroom Clock

June 13, 2026
Nel ASA Stock

Nel ASA Pays $7.5M to End a Lawsuit, but the Market Sees a Bigger Problem: No Orders

June 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Micron’s Index Upgrade Sets Off a $1.1 Trillion Index Rebalancing Act
  • Palantir’s Twin Wins: McCarthy and Kirkland & Ellis Deals Fail to Lift Stock Amid AI Sector Anxiety
  • Deutz’s Dual-Pivot Strategy Gains Traction at Eurosatory, but Investors Demand Hard Orders

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com